Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial
/in Acute Leukemia, Dendritic Cells, International PublicationsCan Dendritic Cell Vaccination Prevent Leukemia Relapse?
/in Acute Leukemia, Dendritic Cells, International PublicationsDendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia
/in Acute Leukemia, Dendritic Cells, International PublicationsHypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine
/in Acute Leukemia, Dendritic Cells, International PublicationsMaintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy
/in Acute Leukemia, Dendritic Cells, International Publications, Malignant LymphomaImmunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?
/in Acute Leukemia, Dendritic Cells, International PublicationsA novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia
/in Acute Leukemia, Dendritic Cells, International PublicationsAnti-cancer vaccine therapy for hematologic malignancies: An evolving era
/in Acute Leukemia, Checkpoint-Inhibitors, Chronic Leukemia, Dendritic Cells, International PublicationsEfficacy of intracellular immune checkpoint-silenced DC vaccine
/in Acute Leukemia, Dendritic Cells, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer